Clinical Trials Logo

Pulmonary Disease clinical trials

View clinical trials related to Pulmonary Disease.

Filter by:

NCT ID: NCT05962645 Enrolling by invitation - Healthy Clinical Trials

Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPD

Start date: May 19, 2023
Phase: Phase 1
Study type: Interventional

Vapendavir (VPV) is potent virostatic antiviral agent active against all known enterovirus species. VPV binds to the viral capsid, thereby inhibiting viral attachment to the target cell and, independently, preventing release of viral RNA (ribonucleic acid) into the cell. Alt VPV-101 is meant to investigate vapendavir in patients with chronic obstructive pulmonary disease (COPD) who develop a rhinoviral infection. This is a Phase 1, open-label, unblinded study. The primary objective of this study is to characterize single and multiple dose (plus a loading dose) plasma PK profiles of VPV in healthy participants (Group A) and participants with COPD (Group B). Group A is an open-label, 2-sequence, and up to a 3-period, cross-over study to assess the single-dose PK parameters and safety of VPV. Healthy participants may opt to participate in only the first 2 periods, all 3 periods or BID dosing, but it is preferred that participants complete all 3 periods. Group B is an open-label, multi-dose investigation of VPV PK parameters and safety in participants with COPD. Post-dose, follow up will continue for a minimum of 14 days and a maximum of 30 days, depending on which Group the participant is in and which periods said participant completes. There is a target for up to 24 adult participants comprised of healthy participants and participants with COPD.

NCT ID: NCT05871710 Not yet recruiting - Pulmonary Disease Clinical Trials

Validity and Reliability of the Turkish Version of the Tele-Pulmonary Rehabilitation Acceptance Scale

Start date: August 1, 2023
Phase:
Study type: Observational [Patient Registry]

The objective of this research is to translate the Tele-Pulmonary Rehabilitation Acceptance Scale into Turkish and assess its reliability and accuracy.

NCT ID: NCT05865769 Not yet recruiting - Pulmonary Disease Clinical Trials

Impact of Pulmonary Function on Vestibular System in Children

Start date: December 20, 2023
Phase:
Study type: Observational

The vestibular system and the pulmonary system are two critical components of the human body that are involved in maintaining balance, coordination, and the exchange of oxygen and carbon dioxide This study aim to investigate the impact of pulmonary function on the vestibular system in children. Children aged 4 to 10 years will be recruited from Future Academy School in March 2023. Pulmonary function will be measured using digital spirometry, and balance will be evaluated using the Mini-SITCIB test, which tested vision, proprioception, and the vestibular system using mobile sensors fixed near the center of gravity. Features from the sensor data will be extracted using Python 3.10 code, and the SPSS program will used to compare these features between the two groups.

NCT ID: NCT05645796 Completed - Pulmonary Disease Clinical Trials

Improved Chest CT Diagnostic and Contrast Medium Administration

Start date: August 2, 2021
Phase: N/A
Study type: Interventional

Investigation of impact of using different CM approaches on contrast enhancement in chest Ct examinations - A prospective study

NCT ID: NCT05619029 Completed - Pulmonary Disease Clinical Trials

Study to Evaluate the Effectiveness of the Device in Detection of Abnormal Findings on X-ray

Start date: June 2, 2021
Phase:
Study type: Observational

This study aims to evaluate the effectiveness of the investigational device (Lunit INSIGHT CXR) in the detection of chest abnormalities.

NCT ID: NCT05614232 Completed - Pulmonary Disease Clinical Trials

Study to Evaluate the Effectiveness of the Device in Detection of Abnormal Findings on Chest X-ray

Start date: February 11, 2020
Phase:
Study type: Observational

This study aims to evaluate the effectiveness of the investigational device (Lunit INSIGHT CXR) in the detection of chest abnormalities

NCT ID: NCT05538975 Completed - COPD Clinical Trials

Effect of Self-directed and Supervised Pulmonary Rehabilitation Approach on Cough and Sputum.

Start date: February 23, 2022
Phase: N/A
Study type: Interventional

Chronic obstructive pulmonary disease (COPD)is a multifactorial, progressive chronic lung disease that causes airflow restriction. Study was conducted To Compare the effects of supervised and self-directed pulmonary rehabilitation on cough and sputum expectoration in patients of chronic obstructive pulmonary disease.

NCT ID: NCT05530408 Recruiting - Pulmonary Disease Clinical Trials

Quantitative Pulmonary Imaging Registry & Biorepository

PIBR
Start date: May 24, 2022
Phase:
Study type: Observational [Patient Registry]

The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.

NCT ID: NCT05526911 Completed - Tuberculosis Clinical Trials

A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Start date: July 20, 2022
Phase: Phase 1
Study type: Interventional

A Phase 1, Drug-Drug Interaction Study to Evaluate the Safety, Tolerability, and the Induction Potential of TBAJ-876 on CYP3A4 and P-glycoprotein and the Inhibition Potential of TBAJ-876 on P-glycoprotein in Healthy Adult Subjects

NCT ID: NCT05495607 Completed - Sepsis Clinical Trials

Continous Renal Replacement Therapy With the CARPEDIEM® in a French National Cohort of 25 Neonates and Small Infants

Start date: December 1, 2018
Phase:
Study type: Observational

Historically, CKRT and hemodialysis were performed in small infants and newborns with devices developed for adults with high rates of complications and mortality. We aim to retrospectively report the first multicenter French experience of CARPEDIEM® use and evaluate the efficacy, feasibility, outcomes, and technical considerations of this new device in a population of neonates and small infant. Compared to adult's device continuous renal replacement therapy with an adapted machine allowed successful blood purification without severe complications even in low birth weight neonates.